{'fraction_non_alphanumeric': 0.03206412825651302, 'fraction_numerical': 0.02404809619238477, 'mean_word_length': 5.578947368421052, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
Rhesus D alloimmunization in pregnancy from 1996 to 2015 in Iceland: a nation‐wide population study prior to routine antenatal anti‐D prophylaxis

Rhesus D (RhD) incompatibility is still the most important cause of hemolytic disease of the fetus and newborn (HDFN) worldwide. The aim of this study was to investigate the incidence, causes, and consequences of anti‐D alloimmunizations in pregnancy in Iceland, prior to implementation of targeted routine antenatal anti‐D prophylaxis (RAADP) in 2018.